FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2074534342> ?p ?o ?g. }

• W2074534342 endingPage "203" @default.
• W2074534342 startingPage "195" @default.
• W2074534342 abstract "BACKGROUND: Dofetilide is a new class III antiarrhythmic drug currently under investigation for the treatment of supraventricular arrhythmias in humans. Dofetilide have been previously shown to be highly effective in terminating and suppressing reentrant atrial flutter in the experimental canine crush-injury model, in which its antiarrhythmic efficacy was correlated with prolongation of wavelength and reduction in dispersion of refractoriness, effects not produced by the class IA antiarrhythmic drug quinidine. The purpose of this study was to evaluate the antiarrhythmic efficacy and mechanisms of action of dofetilide in an experimental model of atrial fibrillation. METHODS AND RESULTS: Dofetilide was administered intravenously to seven open-chest dogs with acute sustained atrial fibrillation induced by rapid atrial pacing for up to 4 hours. Mean atrial effective refractory period (ERP), dispersion of ERP, conduction velocity and wave-length were determined by multipoint right atrial programmed stimulation and activation mappin gusing a 56-electrode mapping plaque on the right atrial free wall. Dofetilide prolonged average ERP by 22% from 104 +/- 13 to 127 +/- 15 ms (P <.001), prolonged maximum ERP by 11% from 129 +/- 7 to 143 +/- 10 (P <.003), had no effect on conduction velocity at 200 ms pacing cycle length, slowed conduction velocity by 16% from 0.89 +/- 12 to 0.75 +/-.17 ms at 150 ms pacing cycle length, slowed conduction velocity by 16% from 0.89 +/- 12 to 0.75 +/-.17 ms at 150 ms pacing cycle length (P <.001), increased wavelength by 20% from 93 +/- 7 to 112 +/- 9 mm (P <.01), reduced dispersion of ERP by 24% from 11.4 +/- 2.9 to 8.7 +/- 2.3 (P =.016), and reduced the number of adjacent electrodes with ERP difference >/=20 ms by 67% from 18.4 +/- 7.1 to 6.1 +/- 4.2 (P <.001). Dofetilide reduced the number of excitation wavelets (total over three beats) entering the region of the mapping plaque by 38% from 5.0 +/-.8 to 3.1 +/-.4 (P <.002). Dofetilide terminated atrial fibrillation in all seven dogs at a mean of 3.4 +/- 2.2 minutes into the loading infusion and prevented reinduction of atrial fibrillation in all seven dogs after completion of the loading infusion, while on maintenance infusion. Time to termination of atrial fibrillation correlated closely with change in ERP (r = 0.78, P =.036). CONCLUSIONS: Dofetilide was highly effective in terminating and suppressing sustained pacing induced atrial fibrillation in this canine model. Time to termination of atrial fibrillation correlated with the degree of change in ERP produced by dofetilide. The mechanism of termination of atrial fibrillation by dofetilide appeared to be a progressive reduction and eventual extinction of re-entrant wavelets. The predominant electrophysiologic effects of dofetilide were prolongation of ERP and wavelength and a reduction in dispersion of refractoriness. Dofetilide had little effect on conduction velocity in this model, except at very short pacing cycle lengths." @default.
• W2074534342 created "2016-06-24" @default.
• W2074534342 creator A5011432597 @default.
• W2074534342 creator A5030681072 @default.
• W2074534342 date "1997-09-01" @default.
• W2074534342 modified "2023-09-26" @default.
• W2074534342 title "Electrophysiologic Effects of the New Class III Antiarrhythmic Drug Dofetilide in an Experimental Canine Model of Pacing-induced Atrial Fibrillation" @default.
• W2074534342 cites W1970906303 @default.
• W2074534342 cites W1981652273 @default.
• W2074534342 cites W1987629095 @default.
• W2074534342 cites W1995182859 @default.
• W2074534342 cites W2003632755 @default.
• W2074534342 cites W2007448071 @default.
• W2074534342 cites W2017179259 @default.
• W2074534342 cites W2050688237 @default.
• W2074534342 cites W2050856282 @default.
• W2074534342 cites W2053028627 @default.
• W2074534342 cites W2058816764 @default.
• W2074534342 cites W2061090096 @default.
• W2074534342 cites W2066195045 @default.
• W2074534342 cites W2078553585 @default.
• W2074534342 cites W2080542032 @default.
• W2074534342 cites W2100769598 @default.
• W2074534342 cites W2117176106 @default.
• W2074534342 cites W2168564324 @default.
• W2074534342 doi "https://doi.org/10.1177/107424849700200306" @default.
• W2074534342 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10684458" @default.
• W2074534342 hasPublicationYear "1997" @default.
• W2074534342 type Work @default.
• W2074534342 sameAs 2074534342 @default.
• W2074534342 citedByCount "14" @default.
• W2074534342 countsByYear W20745343422015 @default.
• W2074534342 countsByYear W20745343422018 @default.
• W2074534342 countsByYear W20745343422019 @default.
• W2074534342 countsByYear W20745343422021 @default.
• W2074534342 countsByYear W20745343422022 @default.
• W2074534342 crossrefType "journal-article" @default.
• W2074534342 hasAuthorship W2074534342A5011432597 @default.
• W2074534342 hasAuthorship W2074534342A5030681072 @default.
• W2074534342 hasConcept C126322002 @default.
• W2074534342 hasConcept C164705383 @default.
• W2074534342 hasConcept C16541007 @default.
• W2074534342 hasConcept C189327125 @default.
• W2074534342 hasConcept C2777796741 @default.
• W2074534342 hasConcept C2778292772 @default.
• W2074534342 hasConcept C2779161974 @default.
• W2074534342 hasConcept C2780339425 @default.
• W2074534342 hasConcept C42219234 @default.
• W2074534342 hasConcept C70616116 @default.
• W2074534342 hasConcept C71924100 @default.
• W2074534342 hasConceptScore W2074534342C126322002 @default.
• W2074534342 hasConceptScore W2074534342C164705383 @default.
• W2074534342 hasConceptScore W2074534342C16541007 @default.
• W2074534342 hasConceptScore W2074534342C189327125 @default.
• W2074534342 hasConceptScore W2074534342C2777796741 @default.
• W2074534342 hasConceptScore W2074534342C2778292772 @default.
• W2074534342 hasConceptScore W2074534342C2779161974 @default.
• W2074534342 hasConceptScore W2074534342C2780339425 @default.
• W2074534342 hasConceptScore W2074534342C42219234 @default.
• W2074534342 hasConceptScore W2074534342C70616116 @default.
• W2074534342 hasConceptScore W2074534342C71924100 @default.
• W2074534342 hasIssue "3" @default.
• W2074534342 hasLocation W20745343421 @default.
• W2074534342 hasLocation W20745343422 @default.
• W2074534342 hasOpenAccess W2074534342 @default.
• W2074534342 hasPrimaryLocation W20745343421 @default.
• W2074534342 hasRelatedWork W1984238571 @default.
• W2074534342 hasRelatedWork W1999596245 @default.
• W2074534342 hasRelatedWork W2047344647 @default.
• W2074534342 hasRelatedWork W2061090096 @default.
• W2074534342 hasRelatedWork W2070676598 @default.
• W2074534342 hasRelatedWork W2074534342 @default.
• W2074534342 hasRelatedWork W2078105309 @default.
• W2074534342 hasRelatedWork W2207597602 @default.
• W2074534342 hasRelatedWork W2355634238 @default.
• W2074534342 hasRelatedWork W3149371561 @default.
• W2074534342 hasVolume "2" @default.
• W2074534342 isParatext "false" @default.
• W2074534342 isRetracted "false" @default.
• W2074534342 magId "2074534342" @default.
• W2074534342 workType "article" @default.